Hot Features
Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
BOCA RATON, Fla., Nov. 14, 2024 (GLOBE NEWSWIRE) -- Entero Therapeutics, Inc., (NASDAQ: ENTO), (“Entero Therapeutics” or the “Company”), a clinical-stage biopharmaceutical company specializing...
Proposed merger to create Nasdaq-listed, clinical-stage biopharmaceutical company focused on advancing (i) Journey’s next-gen, first-in-class ADC-rivalling, nano-immunoconjugates (“NIC”) platform...
BOCA RATON, Fla., Sept. 10, 2024 (GLOBE NEWSWIRE) -- Entero Therapeutics, Inc., (NASDAQ: ENTO), (“Entero Therapeutics” or the “Company”), a clinical-stage biopharmaceutical company specializing...
BOCA RATON, Fla., Aug. 23, 2024 (GLOBE NEWSWIRE) -- Entero Therapeutics, Inc., (NASDAQ: ENTO), (“Entero Therapeutics” or the “Company”), a clinical-stage biopharmaceutical company specializing...
BOCA RATON, Fla., July 31, 2024 (GLOBE NEWSWIRE) -- Entero Therapeutics, Inc., (NASDAQ: ENTO), (“Entero Therapeutics” or the “Company”), a clinical-stage biopharmaceutical company specializing...
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.083 | 21.8421052632 | 0.38 | 0.49 | 0.38 | 50212 | 0.43788031 | CS |
| 4 | -0.1271 | -21.5387222505 | 0.5901 | 0.7208 | 0.38 | 173593 | 0.58636972 | CS |
| 12 | 0.0378 | 8.88993414864 | 0.4252 | 0.8655 | 0.28 | 410455 | 0.56491337 | CS |
| 26 | -2.377 | -83.6971830986 | 2.84 | 2.8599 | 0.185 | 471483 | 0.47565264 | CS |
| 52 | -2.497 | -84.3581081081 | 2.96 | 3.16 | 0.185 | 450970 | 0.47879628 | CS |
| 156 | -2.497 | -84.3581081081 | 2.96 | 3.16 | 0.185 | 450970 | 0.47879628 | CS |
| 260 | -2.497 | -84.3581081081 | 2.96 | 3.16 | 0.185 | 450970 | 0.47879628 | CS |
| Keine Diskussionen Gefunden. |
| Neuen Thread Erstellen |
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
